Received Mar 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | RA |
nauseous; felt lousy/does not feel like herself; having frequent bowel movements; stomach bothering; feeling very tired; This non-serious case was reported by a consumer via call center representative and described the occurrence of tiredness in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose on unknown date). On 18-MAR-2025, the patient received the 2nd dose of Shingrix (right arm). On 18-MAR-2025, less than a day after receiving Shingrix, the patient experienced tiredness (Verbatim: feeling very tired ). On an unknown date, the patient experienced nausea (Verbatim: nauseous ), feeling bad (Verbatim: felt lousy/does not feel like herself), frequent bowel movements (Verbatim: having frequent bowel movements) and stomach discomfort (Verbatim: stomach bothering). The outcome of the tiredness, nausea, feeling bad, frequent bowel movements and stomach discomfort were not resolved. It was unknown if the reporter considered the tiredness, nausea, feeling bad, frequent bowel movements and stomach discomfort to be related to Shingrix. It was unknown if the company considered the tiredness, nausea, feeling bad, frequent bowel movements and stomach discomfort to be related to Shingrix. Additional Information: GSK Receipt Date: 19-DEC-2024 Consumer was the reporter. Reporter stated that she received her second dose of Shingrix 18th March 2025 in her right arm. Consumer stated she began feeling very tired last night and was still feeling tired today. Consumer stated she felt lousy and does not feel like herself. Stated she was nauseous and having frequent bowel movements. Stated if she had known the second dose was going to make her feel like this she would not have had the dose administered.